Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Wino115on Jan 12, 2021 1:39pm
118 Views
Post# 32277160

RE:RE:RE:Anyone want to guess at RBC's new target price?

RE:RE:RE:Anyone want to guess at RBC's new target price?At a minimum, they should have brought you in under the NDA and offered you the equivalent ownership to avoid dilution. Not even giving you an NDA is a snub as a 30% holder in my book. 

Wino115 wrote: SPCEO, you think your avowed disinterest in being "activist" was something they took advantage of -- completely ignoring your logic and your past discussions and warnings?  They may have known you wouldn't really do anything from past behavior.  It's certainly a smack in the face from them though.   Maybe it will be time for us to be more forceful at the meeting this year -- especially on comp and pay plans. I'm good with the new board members coming in. 

Jasonthehumble wrote: Since the majority of us are retail investors, we should all ban together and vote against everything the board and management recommends the next quarterly earnings. They need to see who really is in charge and my hope is that they see how disgruntled we all are.

SPCEO1 wrote: I will guess $1.65.

Of course it will also be interesting to see what changes, if any, Mackie, Canaccord and NBF make too.
 

 




<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse